N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM)
- Citation:
- J Clin Oncol vol 28 (15s) abstr 8572
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 929
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. Dronca D. Perez J. Allred W. Maples E. Creagan B. Pockaj J. Kaur J. Kuebler B. Marchello S. Markovic
- Networks:
- Study
- NCCTG-N0675
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: